Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,483.33p
   
  • Change Today:
      8.33p
  • 52 Week High: 4,400.00p
  • 52 Week Low: 2,300.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 5,985
  • Market Cap: £129.75m
  • Beta: 0.03

Latest ShareCast News

Revenue rises, profit falls for Bioventix

By Josh White

Date: Monday 31 Mar 2025

(Sharecast News) - Bioventix reported a marginal rise in revenue for the six months ended 31 December on Monday, with profit before tax dipping slightly due to higher research and development expenditure.

Director dealings: Bioventix CFO raises stake

By Iain Gilbert

Date: Thursday 31 Oct 2024

(Sharecast News) - Bioventix revealed on Thursday that chief financial officer Bruce Hiscock had acquired 333 ordinary shares in the London-listed antibodies development and supply company.

BioVentix reports year of growth, warns of geopolitical risks

By Josh White

Date: Monday 28 Oct 2024

(Sharecast News) - BioVentix, a UK-based developer of high-affinity monoclonal antibodies for clinical diagnostics, reported a 6% improvement in full-year revenue on Monday, to £13.6m, up from £12.82m in the prior year.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,483.33p
Change Today 8.33p
% Change 0.34 %
52 Week High 4,400.00p
52 Week Low 2,300.00p
Volume 5,985
Shares Issued 5.22m
Market Cap £129.75m
Beta 0.03

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 21-Aug-2025

Time Volume / Share Price
12:07 130 @ 2,452.00p
11:54 17 @ 2,452.00p
11:35 24 @ 2,452.00p
11:00 2,900 @ 2,480.00p
11:00 800 @ 2,480.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page